Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
14.53 USD | -3.39% | +1.39% | -44.08% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 10M | Capitalization | 386M |
---|---|---|---|---|---|
Net income 2024 * | -71M | Net income 2025 * | -86M | EV / Sales 2024 * | - |
Net cash position 2024 * | 311M | Net cash position 2025 * | 430M | EV / Sales 2025 * | -4.4 x |
P/E ratio 2024 * |
-5.12
x | P/E ratio 2025 * |
-4.95
x | Employees | 44 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.39% |
Latest transcript on Tourmaline Bio, Inc.
1 day | -3.39% | ||
1 week | +1.39% | ||
Current month | -7.52% | ||
1 month | -5.55% | ||
3 months | -60.15% | ||
6 months | -17.05% | ||
Current year | -44.08% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 17 M€ | +5.25% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 14.66 | -2.49% | 41 457 |
24-05-17 | 15.04 | +0.27% | 184,989 |
24-05-16 | 15 | -1.64% | 213,801 |
24-05-15 | 15.25 | +5.76% | 178,595 |
24-05-14 | 14.42 | -0.14% | 380,456 |
Delayed Quote Nasdaq, May 20, 2024 at 10:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.08% | 386M | |
+9.80% | 115B | |
+11.94% | 106B | |
-2.62% | 21.96B | |
-13.90% | 21.87B | |
-5.29% | 19.21B | |
-3.58% | 18.08B | |
-38.57% | 17.71B | |
+6.36% | 14.32B | |
+34.49% | 12.42B |
- Stock Market
- Equities
- TRML Stock